VivoSim Labs (VIVS) Current Deferred Revenue (2011 - 2019)
VivoSim Labs (VIVS) posted Current Deferred Revenue of $532000.0 for Q2 2019, up 1.33% on a QoQ basis from $525000.0 in Q1 2019, and down 15.29% year-over-year from $628000.0 in Q2 2018.
Analysis
VivoSim Labs (VIVS) Current Deferred Revenue (2011 - 2019) Analysis & Trends
VivoSim Labs has reported Current Deferred Revenue for 9 years, with the latest figure at $532000.0 in Q2 2019.
- On a quarterly basis, Current Deferred Revenue fell 15.29% year-over-year to $532000.0 in Q2 2019; TTM through Jun 2019 was $532000.0, a 15.29% decrease from a year earlier, with the FY2019 full-year figure at $525000.0, down 21.41% from the prior year.
- Current Deferred Revenue was $532000.0 for Q2 2019 at VivoSim Labs, up from $525000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $1.4 million in Q4 2015, with the low at $479000.0 in Q3 2016.
- Average Current Deferred Revenue over 5 years is $807611.1, with a median of $661000.0 recorded in 2017.
- The sharpest annual moves came in 2015 and 2016: Current Deferred Revenue soared 895.14% in 2015, then tumbled 65.83% in 2016.
- Over 5 years, Current Deferred Revenue stood at $1.4 million in 2015, then sank by 57.06% to $620000.0 in 2016, then jumped by 38.23% to $857000.0 in 2017, then slumped by 32.32% to $580000.0 in 2018, then decreased by 8.28% to $532000.0 in 2019.
- The last three Current Deferred Revenue figures came in at $532000.0 (Q2 2019), $525000.0 (Q1 2019), and $580000.0 (Q4 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | 532,000.00 |
| Mar 31, 2019 | 525,000.00 |
| Dec 31, 2018 | 580,000.00 |
| Sep 30, 2018 | 619,000.00 |
| Jun 30, 2018 | 628,000.00 |
| Mar 31, 2018 | 668,000.00 |
| Dec 31, 2017 | 857,000.00 |
| Sep 30, 2017 | 654,000.00 |
| Jun 30, 2017 | 854,000.00 |
| Mar 31, 2017 | 582,000.00 |
| Dec 31, 2016 | 620,000.00 |
| Sep 30, 2016 | 479,000.00 |
| Jun 30, 2016 | 791,000.00 |
| Mar 31, 2016 | 1.11 Mn |
| Dec 31, 2015 | 1.44 Mn |
| Sep 30, 2015 | 1.40 Mn |
| Jun 30, 2015 | 1.43 Mn |
| Mar 31, 2015 | 759,000.00 |
| Dec 31, 2014 | 646,000.00 |
| Sep 30, 2014 | 615,000.00 |